claim: erythrocytes inhibit complement activation in patients with covid-19
evidence_1: these findings suggest that novel erythrocyte- based diagnostics provide a method to identify patients with dysregulated complement activation.", "here we report the presence of complement activation products on circulating erythrocytes from hospitalized covid-19 patients using flow cytometry.")